Rani Therapeutics Holdings
NASDAQ: RANISan Jose, US · Founded 2021 · California corporation · 1 known investors
Biotech
Founders & leadership
TI
Talat ImranExecutive
SS
Svai SanfordExecutive
MH
Mir HashimExecutive
Board
AB
Abraham BassanBoard director
VB
Vasudev Bailey, M.D.Board director
MI
JB
Jean-Luc ButelBoard director
LR
Lisa RomettyBoard director
DA
Dennis AusielloBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$60.3M disclosed across 1 round · 2025
▶$60.3MraisedNov 2025 · 15 investors · BiotechnologyRule 506(b)
▶$60.3MraisedNov 2025 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Talat ImranExecutive Officer, Director
- Abraham BassanDirector
- Vasudev Bailey, M.D.Director
- Svai SanfordExecutive Officer
- Mir HashimExecutive Officer
- Jean-Luc ButelDirector
- Lisa RomettyDirector
- Mir ImranDirector
- Dennis AusielloDirector
- Offering amount
- $60.3M
- Amount sold
- $60.3M
- Sales commissions
- $2.9M
- Placement agents
- Maxim Group LLC, H.C. Wainwright & Co, LLC
- First sale
- Oct 2025
- Incorporated
- Corporation, California, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Rani Therapeutics Holdings's investors?
- Rani Therapeutics Holdings's investors include InCube Ventures.
- How much funding has Rani Therapeutics Holdings raised?
- Rani Therapeutics Holdings has disclosed $60.3M raised across 1 round.
- Where is Rani Therapeutics Holdings headquartered?
- Rani Therapeutics Holdings is headquartered in San Jose, US.